A randomized trial of oral gamma aminobutyric acid (gaba) or the combination of gaba with glutamic acid decarboxylase (gad) on pancreatic islet endocrine function in children with newly diagnosed type 1 diabetes

HIGHLIGHTS

• who: Alexandra Martin from the Endocrine assays, peptide, glucose and glucagon were measured in the University of Alabama Core Metabolic Laboratory and as previously noted, peptide was measured by a two-site immunoenzymometric analyzer (, AIA-Pack, TOSOH, San Francisco, CA) and glucagon by radioimmunassay (Millipore Sigma, Burlington, MA). Antibodies to GAD65, IA512, and Zinc , Transporter were assayed commercially by Labcorp (Burlington, NC) as standard of care. have published the article: A randomized trial of oral gamma aminobutyric acid (GABA) or the combination of GABA with glutamic acid decarboxylase (GAD) on pancreatic islet endocrine function in children with . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.